Imperial College London

DrAnikaSinganayagam

Faculty of MedicineDepartment of Infectious Disease

Clinical Lecturer
 
 
 
//

Contact

 

anika.singanayagam

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Summary

Dr Anika Singanayagam is a Clinical Lecturer in the Section of Adult Infectious Disease at Imperial College London. Her current work is in the laboratory of Prof Chris Chiu as Principal Investigator on a SARS-CoV-2 controlled human challenge study. She also actively collaborates on the ATACCC SARS-CoV-2 household contact study led by Prof Ajit Lalvani, with an interest in the virology and transmission of SARS-CoV-2 and other respiratory viruses. 

Anika graduated in Medicine (BM BCh BA(Hons)) from Oxford University in 2008. She completed general medical training in London and subsequently entered Infectious Diseases specialty training as an Academic Clinical Fellow in 2012.

Her PhD research (funded by a national Wellcome Trust Clinical Research Training Fellowship) on pandemic influenza viruses was in the laboratory of Prof Wendy Barclay at Imperial College. Using in vitro and animal models, she demonstrated how influenza virus stability is important for human adaptation and airborne transmission. More detail can be found here and here. Her doctoral work also involved investigating virological causes of reduced effectiveness of the nasally-administered live attenuated influenza vaccine.

Anika is also a final year honorary Specialist Registrar in Infectious Diseases and General Internal Medicine at Imperial College Healthcare NHS Trust, and Honorary Clinical Fellow at UKHSA. At UKHSA, she was a key member of the Virology Cell of the COVID-19 National Incident Management Team from January 2020, providing technical and scientific input on virology, transmission and testing for SARS-CoV-2, contributing to national public health policy.

Publications

Journals

Hakki S, Zhou J, Jonnerby J, et al., 2022, Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study, The Lancet Respiratory Medicine, Vol:10, ISSN:2213-2600, Pages:1061-1073

Houston H, Hakki S, Pillay TD, et al., 2022, Broadening symptom criteria improves early case identification in SARS-CoV-2 contacts, European Respiratory Journal, Vol:60, ISSN:0903-1936

Deeks JJ, Singanayagam A, Houston H, et al., 2022, SARS-CoV-2 antigen lateral flow tests for detecting infectious people: linked data analysis, Bmj-british Medical Journal, Vol:376, ISSN:0959-535X

Singanayagam A, Hakki S, Dunning J, et al., 2022, Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study., The Lancet. Infectious Diseases, Vol:22, ISSN:1473-3099, Pages:183-195

Singanayagam A, Hakki S, Dunning J, et al., 2022, Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study, The Lancet Infectious Diseases, Vol:22, ISSN:1473-3099, Pages:183-195

More Publications